Annexon (ANNX) News Today → The new masters of energy (From Porter & Company) (Ad) Free ANNX Stock Alerts $5.74 -0.15 (-2.55%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 6:55 PM | marketbeat.comBain Capital Life Sciences Investors LLC Purchases 2,359,793 Shares of Annexon, Inc. (NASDAQ:ANNX)Bain Capital Life Sciences Investors LLC grew its position in shares of Annexon, Inc. (NASDAQ:ANNX - Free Report) by 41.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,061,719 shares of the company's stock after buyiJune 7 at 1:20 PM | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 7.5%Annexon (NASDAQ:ANNX) Trading Down 7.5%June 7 at 6:34 AM | americanbankingnews.comAnnexon (NASDAQ:ANNX) Sees Unusually-High Trading VolumeJune 6 at 11:47 AM | marketbeat.comAnnexon (NASDAQ:ANNX) Shares Gap Down to $6.79Annexon (NASDAQ:ANNX) Shares Gap Down to $6.79June 6 at 5:50 AM | americanbankingnews.comAnnexon (NASDAQ:ANNX) Shares Gap Up to $4.58June 6 at 4:48 AM | americanbankingnews.comAnnexon's (ANNX) "Overweight" Rating Reaffirmed at Cantor FitzgeraldJune 6 at 1:42 AM | americanbankingnews.comAnnexon (NASDAQ:ANNX) Rating Reiterated by HC WainwrightJune 5 at 11:04 PM | globenewswire.comAnnexon Announces Pricing of $125 Million Underwritten Public OfferingJune 5 at 12:23 PM | marketbeat.comAnnexon (NASDAQ:ANNX) Sees Large Volume IncreaseAnnexon (NASDAQ:ANNX) Sees Unusually-High Trading VolumeJune 5 at 10:10 AM | marketbeat.comAnnexon (NASDAQ:ANNX) Rating Reiterated by Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Annexon in a report on Wednesday.June 5 at 3:18 AM | americanbankingnews.comAnnexon's (ANNX) Buy Rating Reaffirmed at Needham & Company LLCJune 4, 2024 | globenewswire.comAnnexon Announces Proposed Public Offering of Common StockJune 4, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Given Buy Rating at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and set a $16.00 target price on shares of Annexon in a research report on Tuesday.June 4, 2024 | reuters.comAnnexon's neurological disorder drug meets main goal of late-stage studyJune 3, 2024 | globenewswire.comAnnexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 DataMay 30, 2024 | americanbankingnews.comShort Interest in Annexon, Inc. (NASDAQ:ANNX) Rises By 25.3%May 17, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Receives Consensus Recommendation of "Buy" from BrokeragesAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) has been given a consensus recommendation of "Buy" by the six analysts that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have covered theMay 16, 2024 | globenewswire.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)May 16, 2024 | marketbeat.comFY2024 EPS Estimates for Annexon, Inc. (NASDAQ:ANNX) Lifted by Cantor FitzgeraldAnnexon, Inc. (NASDAQ:ANNX - Free Report) - Cantor Fitzgerald raised their FY2024 earnings estimates for Annexon in a research note issued on Tuesday, May 14th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will post earnings per share of ($0.88) for the year, up fromMay 15, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Price Target Cut to $10.00Wells Fargo & Company lowered their price objective on shares of Annexon from $12.00 to $10.00 and set an "overweight" rating for the company in a research note on Wednesday.May 15, 2024 | marketbeat.comFY2028 EPS Estimates for Annexon, Inc. Cut by Analyst (NASDAQ:ANNX)Annexon, Inc. (NASDAQ:ANNX - Free Report) - Equities research analysts at HC Wainwright reduced their FY2028 earnings per share (EPS) estimates for Annexon in a research note issued to investors on Tuesday, May 14th. HC Wainwright analyst A. Fein now anticipates that the company will earn $1.14 pMay 14, 2024 | markets.businessinsider.comBuy Rating on Annexon Biosciences Backed by Efficacious ANX007 Data and Meticulous Phase 3 Trial DesignMay 14, 2024 | finance.yahoo.comWe Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business GrowthMay 13, 2024 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Annexon (NASDAQ:ANNX)Needham & Company LLC restated a "buy" rating and set a $16.00 price objective on shares of Annexon in a research report on Monday.May 13, 2024 | globenewswire.comAnnexon Reports First Quarter 2024 Financial Results and Key Anticipated MilestonesMay 9, 2024 | globenewswire.comAnnexon Biosciences to Present at the Bank of America Health Care ConferenceMay 7, 2024 | globenewswire.comAnnexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual MeetingMay 1, 2024 | globenewswire.comAnnexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual MeetingApril 29, 2024 | marketbeat.comShort Interest in Annexon, Inc. (NASDAQ:ANNX) Grows By 15.3%Annexon, Inc. (NASDAQ:ANNX - Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 4,140,000 shares, a growth of 15.3% from the March 31st total of 3,590,000 shares. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is presently 2.6 days.April 24, 2024 | marketbeat.comCantor Fitzgerald Reaffirms "Overweight" Rating for Annexon (NASDAQ:ANNX)Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Annexon in a research note on Wednesday.April 20, 2024 | morningstar.comAnnexon Inc Ordinary SharesApril 19, 2024 | marketbeat.comVontobel Holding Ltd. Decreases Stock Position in Annexon, Inc. (NASDAQ:ANNX)Vontobel Holding Ltd. cut its holdings in Annexon, Inc. (NASDAQ:ANNX - Free Report) by 27.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 650,911 shares of the company's stock after selling 247,874 shaApril 17, 2024 | finance.yahoo.comAre Medical Stocks Lagging Annexon (ANNX) This Year?April 17, 2024 | finance.yahoo.comAre Medical Stocks Lagging Annexon (ANNX) This Year?April 16, 2024 | globenewswire.comAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)April 16, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Shares Gap Down to $5.74Annexon (NASDAQ:ANNX) Shares Gap Down to $5.74April 15, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Trading Down 3.5%Annexon (NASDAQ:ANNX) Shares Down 3.5%April 12, 2024 | marketbeat.comAnnexon, Inc. (NASDAQ:ANNX) Short Interest UpdateAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,590,000 shares, a growth of 44.2% from the March 15th total of 2,490,000 shares. Based on an average trading volume of 1,570,000 shares, the days-to-cover ratio is currently 2.3 days.April 11, 2024 | markets.businessinsider.comBuy Rating on Annexon Biosciences: Promising Pipeline and Strategic Growth PotentialApril 11, 2024 | insidertrades.comInsider Buying: Annexon, Inc. (NASDAQ:ANNX) Director Buys 3,200 Shares of StockApril 10, 2024 | marketbeat.comInsider Buying: Annexon, Inc. (NASDAQ:ANNX) Director Purchases 3,200 Shares of StockAnnexon, Inc. (NASDAQ:ANNX - Get Free Report) Director William H. Carson bought 3,200 shares of the company's stock in a transaction on Monday, April 8th. The shares were purchased at an average cost of $6.07 per share, for a total transaction of $19,424.00. Following the transaction, the director now owns 3,200 shares in the company, valued at $19,424. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.April 9, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Shares Gap Down to $6.05Annexon (NASDAQ:ANNX) Shares Gap Down to $6.05April 8, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Shares Down 4.5% Annexon (NASDAQ:ANNX) Trading Down 4.5%April 3, 2024 | globenewswire.comAnnexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare ConferenceApril 1, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)April 1, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) PT Raised to $13.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. upped their price objective on shares of Annexon from $11.00 to $13.00 and gave the stock an "overweight" rating in a research note on Monday.March 29, 2024 | marketbeat.comFY2024 EPS Estimates for Annexon, Inc. Lifted by HC Wainwright (NASDAQ:ANNX)Annexon, Inc. (NASDAQ:ANNX - Free Report) - Investment analysts at HC Wainwright raised their FY2024 earnings per share estimates for Annexon in a report released on Wednesday, March 27th. HC Wainwright analyst A. Fein now expects that the company will post earnings of ($1.50) per share for the yMarch 28, 2024 | marketbeat.comAnnexon (NASDAQ:ANNX) Price Target Raised to $10.00 at Bank of AmericaBank of America lifted their target price on shares of Annexon from $7.00 to $10.00 and gave the company a "buy" rating in a research note on Thursday.March 28, 2024 | markets.businessinsider.comAnticipating Growth: Positive Outlook for Annexon Biosciences Amid Upcoming Clinical Trials and New Data ReadoutsMarch 28, 2024 | marketbeat.comHC Wainwright Comments on Annexon, Inc.'s Q1 2024 Earnings (NASDAQ:ANNX)Annexon, Inc. (NASDAQ:ANNX - Free Report) - Equities researchers at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of Annexon in a report released on Wednesday, March 27th. HC Wainwright analyst A. Fein expects that the company will earn ($0.35) per share for the quart Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (Ad)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from these levels. But there are at least 10 different coins that I like even better. ANNX Media Mentions By Week ANNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANNX News Sentiment▼0.490.73▲Average Medical News Sentiment ANNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANNX Articles This Week▼182▲ANNX Articles Average Week Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TBPH News Today PLRX News Today ENTA News Today DCPH News Today VERA News Today MRVI News Today AMPH News Today AMRX News Today RCKT News Today ARVN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANNX) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored